3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Head and Neck Neoplasms
4
Prostatic Neoplasms
3
Breast Neoplasms
3
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Cervical Cancer
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Meningioma
1
Leukemia, Lymphoid
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Gynecologic Cancer
1
Genetic Testing
1
Endometrial Neoplasms
1
Dehydration
1
Communication
1
Colonic Neoplasms
1
Colon or Upper Rectum Adenocarcinoma
1
Interventions
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
Capecitabine
3
zolbetuximab
2
trastuzumab deruxtecan
2
pembrolizumab
2
Ramucirumab
2
Paclitaxel
2
repotrectinib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
durvalumab
1
darolutamide
1
aldesleukin
1
Vinorelbine
1
Radiosurgery
1
Radiation
1
Prednisone
1
Prednisolone
1
Pemetrexed
1
PF06821497
1
Nivolumab
1
Negative-Pressure Wound Therapy
1
Microscopy, Confocal
1
MORAb-202
1
Irinotecan
1
Immunotherapy
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Surveys and Questionnaires
×
30 days
×
Clear all
No trials found.